Navigation Links
Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Date:2/29/2008

WARNER CHILCOTT LIMITED

Reconciliation of Net Income / (Loss) to Adjusted EBITDA

(In thousands of U.S. dollars)

(Unaudited)

Quarter Ended Year Ended

Dec-31-07 Dec-31-06 Dec-31-07 Dec-31-06

RECONCILIATION TO ADJUSTED

EBITDA:

Net income / (loss) - GAAP $19,687 $(8,520) $28,875 $(153,510)

+ Interest expense, net 27,284 60,214 117,618 206,994

+ Provision for income taxes 12,195 (19,508) 18,416 (11,147)

+ Stepped up basis of inventory

in cost of sales - - - 1,464

+ Non-operating, sponsors'

management fees in SG&A - - - 31,173

+ Non-cash share-based

compensation expense 1,085 1,711 6,115 17,787

+ Depreciation 2,892 2,171 10,250 7,177

+ Amortization of intangible

assets 56,169 68,300 228,330 253,425

+ R&D milestone expense 500 - 14,500 3,000

+ Accretion on preferred stock

in subsidiary - - - 26,190

+ Litigation settlements - - 26,500 -

Adjusted EBITDA of WCL, as

defined $119,812 $104,368 $450,604 $382,553

+ Expenses of WCL and other 5,637 2,465 10,687 2,769

Adjusted EBITDA of Warner

Chilcott Holdings Company

III, Limited., as defined $125,449 $106,833 $461,291 $385,322

Note: Warner Chilcott Holdings Company III, Limited and certain of its

subsidiaries are parties to our credit agreement and the indenture

govern
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
6. Cepheid Reports Fourth Quarter and Full Year 2007 Results
7. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
8. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
9. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
10. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
11. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Greenville, SC (PRWEB) August 22, 2014 ... that indisputable acknowledgement is a national disgrace. Furthermore, ... part in establishing the current, deplorable state of ... outlined "5 great mistakes," to merely serve as ... convey the extent of colossal failure(s) that have ...
(Date:8/21/2014)... Institute for Molecular Medicine Finland (FIMM), University of ... novel "man and machine" decision support system for ... described in PLOS One scientific journal ... computer vision algorithms similar to those used in ... the diagnostically most relevant areas. Tablet computers can ...
(Date:8/21/2014)... Ireland , August 21, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the addition ... 2014-2018"  report to their offering.  ... known as hormone therapy, is a means ... being produced by the body. This type ...
(Date:8/21/2014)... Rochelle, N.Y. (PRWEB) August 21, 2014 ... is the first private college in the Mid-Hudson Region ... College will now begin accepting applications from qualified “high-technology” ... , “We are very pleased to have been selected ... support Governor Cuomo’s transformative initiative to stimulate economic development ...
Breaking Biology Technology:5 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3
... Inc., a private clinical-stage biotherapeutics company focused on the ... cancer, today announced that key data from its Phase ... along with data from other JX-594 clinical trials, will ... Cell Therapy (ASGCT) Annual Meeting taking place May 18-21, ...
... Reportlinker.com announces that a new market research ... Industrial Biotechnology China News 1104 ... the regional turbulence in Egypt and Libya areas, ... at USD102 per barrel on March 2, 2011; ...
... SHENYANG, China, May 11, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ... a leading China-based biotechnology company focused on researching, developing, ... financial results for the first quarter ended March 31, ... Financial Highlights: Total net ...
Cached Biology Technology:Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting 2Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting 3Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting 4Reportlinker Adds Industrial Biotechnology China News 1104 2Reportlinker Adds Industrial Biotechnology China News 1104 33SBio Inc. Announces Unaudited First Quarter 2011 Results 23SBio Inc. Announces Unaudited First Quarter 2011 Results 33SBio Inc. Announces Unaudited First Quarter 2011 Results 43SBio Inc. Announces Unaudited First Quarter 2011 Results 53SBio Inc. Announces Unaudited First Quarter 2011 Results 63SBio Inc. Announces Unaudited First Quarter 2011 Results 73SBio Inc. Announces Unaudited First Quarter 2011 Results 83SBio Inc. Announces Unaudited First Quarter 2011 Results 93SBio Inc. Announces Unaudited First Quarter 2011 Results 103SBio Inc. Announces Unaudited First Quarter 2011 Results 113SBio Inc. Announces Unaudited First Quarter 2011 Results 123SBio Inc. Announces Unaudited First Quarter 2011 Results 13
(Date:8/22/2014)... release is available in German . ... substances, in PCFs proteins are fixated in a way ... crystals. Next, the HZB and Fudan University researchers are ... as functional materials. Their findings are being published today ... 10.1038/ncomms5634). , Proteins are sensitive molecules. Everyone knows that ...
(Date:8/22/2014)... rhino reproduction in Europe highlights how hormone analysis ... Researchers from Chester Zoo, The University of Manchester ... six-year study which encompassed 90% of European population ... the research as part of her PhD at ... black rhinoceros breed well in captivity, not all ...
(Date:8/22/2014)... and can reduce free radical damage. Can ... stress? Jianbo Zhao and co-workers from the ... China discovered that green tea polyphenol effectively ... indicating green tea polyphenols play a protective ... stress. The relevant study has been published ...
Breaking Biology News(10 mins):Proteins: New class of materials discovered 2Hormone analysis helps identify horny rhinos 2
... Research (LICR) and the University of California, San Diego ... identifying functional elements in the human genome, according to ... , While the DNA sequence can identify genes (the ... fundamental questions of 'how,' 'when' and 'where' gene products ...
... be caused by hypoglycemic coma actually occurs when glucose is ... rodents led by researchers at the San Francisco VA Medical ... and may be of clinical significance for the treatment of ... cannot be immediately extrapolated to humans. , Insulin is ...
... over a scientific paper that is putting Korea's scientific ... pitted a young Korean doctor, Jeong Hwan Kim, against ... the most powerful players in the country's struggle for ... threatening to disrupt Korea's efforts to recover scientific credibility ...
Cached Biology News:Beyond the DNA: Chemical signatures reveal genetic switches in the genome 2Glucose triggers brain cell death in rats after hypoglycemic coma 2Glucose triggers brain cell death in rats after hypoglycemic coma 3Row over study puts Korea's scientific community under scrutiny again 2
... of RNase A-type ribonucleases Product Description: ,QIAGEN ... origin that binds noncovalently and inactivates a ... and C). It does not interfere with ... CL3. QIAGEN RNase Inhibitor inhibits greater than ...
...
... Radiochemical Purity is >95%\nNEN Radiolabeled Ligands\n\nReceptor-related ... continual availability of new radiolabeled ligands selected ... offers a wide range of products and ... including over 400 state-of-the-art radioligands. If you ...
... Thermus aquaticus (strain YT1) is cloned ... highly purified to produce Taq DNA ... amplification and sequence testing of DNA ... Taq DNA polymerase has been tested ...
Biology Products: